Comparative Transcriptome Analysis of Organ-Specific Adaptive Responses to Hypoxia Provides Insights to Human Diseases

Genes (Basel). 2022 Jun 19;13(6):1096. doi: 10.3390/genes13061096.

Abstract

The common carp is a hypoxia-tolerant fish, and the understanding of its ability to live in low-oxygen environments has been applied to human health issues such as cancer and neuron degeneration. Here, we investigated differential gene expression changes during hypoxia in five common carp organs including the brain, the gill, the head kidney, the liver, and the intestine. Based on RNA sequencing, gene expression changes under hypoxic conditions were detected in over 1800 genes in common carp. The analysis of these genes further revealed that all five organs had high expression-specific properties. According to the results of the GO and KEGG, the pathways involved in the adaptation to hypoxia provided information on responses specific to each organ in low oxygen, such as glucose metabolism and energy usage, cholesterol synthesis, cell cycle, circadian rhythm, and dopamine activation. DisGeNET analysis showed that some human diseases such as cancer, diabetes, epilepsy, metabolism diseases, and social ability disorders were related to hypoxia-regulated genes. Our results suggested that common carp undergo various gene regulations in different organs under hypoxic conditions, and integrative bioinformatics may provide some potential targets for advancing disease research.

Keywords: GABA; cell proliferation; cholesterol synthesis; circadian rhythm; dopamine; glucose metabolism; glutamate; hypoxia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carps*
  • Gene Expression Profiling
  • Humans
  • Hypoxia* / genetics
  • Hypoxia* / metabolism
  • Oxygen
  • Transcriptome / genetics

Substances

  • Oxygen

Grants and funding

This research was funded by Ministry of Science and Technology, Taiwan. Title: Genetic basis and molecular mechanisms of Carassius auratus and Cyprinus carpio in hypoxia adaptation (MOST 104-2321-B-019-005-MY3).